DHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Danaher Corp (DHR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and potential for recovery in key markets make it a solid choice for long-term growth. While technical indicators are mixed, the overall outlook remains favorable.
The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 34.812, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 186.094, with resistance at 195.078.
Upcoming Q1 2026 earnings call on April 21, 2026, could act as a potential catalyst.
Technical indicators show bearish moving averages, and the stock is trading below its pivot point. No significant hedge fund or insider trading activity to support bullish sentiment.
In Q4 2025, Danaher reported revenue of $6.838 billion (+4.59% YoY), net income of $1.197 billion (+10.22% YoY), and EPS of $1.68 (+12.75% YoY). However, gross margin declined to 58.2% (-2.18% YoY). Overall, the company demonstrated solid growth trends despite a slight margin contraction.
Analysts are highly positive on Danaher, with multiple firms raising price targets recently. Baird, Deutsche Bank, BofA, Evercore ISI, Jefferies, TD Cowen, and Guggenheim have all increased their targets, with the highest being $275. Analysts highlight recovery in key markets, potential upside in life sciences, and a constructive M&A backdrop as key drivers for growth.
